West Pharmaceutical Services Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $150.7M | $143.6M | $95.6M | $127.1M | $112.3M | $80.7M | $75.5M | $65.3M |
| Depreciation & Amortization | $96.7M | $90.7M | $89.9M | $90.0M | $85.2M | $76.9M | $75.7M | $73.2M |
| Depreciation | $94.3M | $88.1M | $86.1M | $84.8M | $81.0M | $72.8M | $71.1M | $68.8M |
| Amortization | $2.4M | $2.6M | $3.5M | $4.9M | $3.9M | $3.9M | $4.3M | $4.1M |
| Stock-Based Compensation | $16.1M | $19.5M | $29.6M | $18.6M | $21.2M | $15.5M | $8.4M | $7.8M |
| Net Cash from Operating Activities | $263.3M | $219.4M | $212.4M | $182.9M | $220.5M | $187.4M | $130.7M | $138.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $130.8M | $170.2M | $131.6M | $111.9M | $151.9M | $131.3M | $95.4M | $71.1M |
| Business Acquisitions | $0 | — | — | — | — | $0 | $0 | $3.7M |
| Net Cash from Investing Activities | $-133.6M | $-175.8M | $-129.5M | $-104.0M | $-149.9M | $-116.0M | $-120.5M | $-74.0M |
| Financing Activities | ||||||||
| Dividends Paid | $39.1M | $35.8M | $32.4M | $29.1M | $26.7M | $24.9M | $23.2M | $21.7M |
| Stock Repurchases | $74.4M | $52.2M | $0 | $0 | — | $4.7M | $3.5M | $2.1M |
| Net Cash from Financing Activities | $-109.0M | $-113.9M | $-41.5M | $-30.8M | $-5.1M | $-3.4M | $-24.7M | $-34.0M |
| Net Change in Cash | $32.9M | $-71.6M | $19.3M | $25.3M | $68.1M | $70.1M | $-18.4M | $27.1M |
| Free Cash Flow | $132.5M | $49.2M | $80.8M | $71.0M | $68.6M | $56.1M | $35.3M | $67.2M |